Diagnostic Factors Associated with Sarcoidosis in Patients Referred for EBUS-TBNA Due to Mediastinal Lymphadenopathy
Advances in Respiratory Medicine · 16.03.2026 · 94 (2) · 19
DOI: 10.3390/arm94020019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Respiratory Medicine, online erschienen am 16.03.2026. Verfasst von Paweł Zając und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, University of Rzeszów, 35-241 Rzeszów, Poland. Hauptthemen laut MEDLINE: Lymphadenopathy, Endoscopic Ultrasound-Guided Fine Needle Aspiration, Sarcoidosis. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Sarcoidosis is a multisystem granulomatous disease of unknown aetiology that frequently presents with mediastinal lymphadenopathy and often requires invasive diagnostic procedures. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used in this setting; however, a definitive diagnosis cannot always be established at first attempt. This study aimed to identify clinical, laboratory, and radiological factors associated with a definitive diagnosis of sarcoidosis in patients referred for EBUS-TBNA. A retrospective analysis was performed including patients undergoing first-time ever EBUS-TBNA for mediastinal lymphadenopathy over a 12-month period. Demographic data, clinical features suggestive of sarcoidosis, chest computed tomography findings, and white blood cell count, were analysed, and definitive diagnoses were established based on cytological results and available follow-up data. Younger age (≤55 years), female sex, the absence of a pulmonary mass >10 mm on imaging, normal white blood cell count, and the presence of clinical features typical of sarcoidosis were significantly associated with a definitive diagnosis of sarcoidosis. Based on these variables, two point-based diagnostic scoring models were developed, demonstrating clinically relevant discriminatory performance. Readily available pre-procedural clinical and radiological factors may assist in estimating the probability of sarcoidosis in patients undergoing EBUS-TBNA for mediastinal lymphadenopathy and may support risk stratification and clinical decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, University of Rzeszów, 35-241 Rzeszów, Poland.
- Independent Researcher, 35-241 Rzeszów, Poland.
- Faculty of Management, Media and Technology, Andrzej Frycz Modrzewski Krakow University, 30-705 Kraków, Poland.
- Department of Pathology, University of Rzeszów, 35-241 Rzeszów, Poland.
Zitieren
APA
Zając, P., Zając, M., Kądziołka, W., Sokołowski, A., & Kaznowska, E. (2026). Diagnostic Factors Associated with Sarcoidosis in Patients Referred for EBUS-TBNA Due to Mediastinal Lymphadenopathy. Advances in Respiratory Medicine, 94(2), 19. https://doi.org/10.3390/arm94020019
Vancouver
Zając P, Zając M, Kądziołka W, Sokołowski A, Kaznowska E. Diagnostic Factors Associated with Sarcoidosis in Patients Referred for EBUS-TBNA Due to Mediastinal Lymphadenopathy. Advances in Respiratory Medicine. 2026;94(2):19. doi:10.3390/arm94020019
BibTeX
@article{Zajc2026,
author = {Zając, Paweł and Zając, Monika and Kądziołka, Wojciech and Sokołowski, Andrzej and Kaznowska, Ewa},
title = {Diagnostic Factors Associated with Sarcoidosis in Patients Referred for EBUS-TBNA Due to Mediastinal Lymphadenopathy},
journal = {Advances in Respiratory Medicine},
year = {2026},
volume = {94},
number = {2},
pages = {19},
doi = {10.3390/arm94020019}
}
EUVIMED